The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
The surgical stapler is available for wound closure and thoracic and intra-abdominal resections. The primary advantage of a surgical stapler is that it saves time and provides more conventional surgical techniques when compared to traditional surgical techniques.
The North America surgical stapling market size was valued to be around $XX million in 2018 and is expected to grow at a CAGR of around 6.89% over the forecast period. The regional market is expected to exhibit lucrative growth opportunities in the coming years owing to the increasing preference for staples over sutures.
The market in North America is expected to undergo significant growth during the forecasting years because of the increasing incidence of gastrointestinal disorders and chronic diseases such as colon cancer, rectal cancer, and severe abdominal diseases. The rapid shift from inpatient surgical therapy to outpatient surgical procedures with technologically advanced devices offered by leading vendors in the region is also a driving factor for the market expansion. This is expected to propel the demand for surgical procedures in North America further.
The United States and Canada are considered for market analysis. The US had been the first country to witness a surgery performed with single-use surgical stapling devices. The products offered by the market provides greater energy density, longer life cycle, and improved reliability. Hence, they have a higher adoption rate among the consumer base in the region.
The major market players operating in the region that have been profiled in the report are Medtronic PLC, St. Jude Medical Inc. (Acquired By Abbott Laboratories), Johnson & Johnson, Stryker Corporation, Intuitive Surgical, Dextera Surgical, Abbott Vascular Inc., Boston Scientific Corporation, Cook Medical LLC, Grena, Smith and Nephew PLC, ConMed Corporation, Ethicon Inc., 3M Company, and Atricure Inc.